REQUEST A DEMO
Total
USD $0.00
Search more companies

Salve Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Salve Pharmaceuticals Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Salve Pharmaceuticals Private Limited is an unlisted company, incorporated on 31/01/2006. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24232DL2006PTC145607 and registration number is 145607. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Property No. 48, 2Nd Floor Rama Road, Najafgarh Industrial Area
West Delhi; Delhi; Postal Code: 110015

Contact Details: Purchase the Salve Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Salve Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Salve Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Salve Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 31, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Salve Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
29.88%
Total operating revenue
31.63%
Operating profit (EBIT)
82.39%
EBITDA
93.93%
Net Profit (Loss) for the Period
64.25%
Total assets
49.95%
Total equity
29.11%
Operating Profit Margin (ROS)
0.91%
Net Profit Margin
0.43%
Return on Equity (ROE)
4.82%
Debt to Equity Ratio
365.54%
Quick Ratio
0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?